Niki BioSolutions, Inc. NIKI
1.76 USD +0.07 (+4.14%)
At closeNov 3, 2026, 4:00 PM EST
1.74 -0.02 -1.14%
After hours · Nov 3, 4:00 PM ET
1.69 Day range 1.80
1.67 52-week range 17.20
- YTD
- -83.40%
- 1 year
- -87.61%
News
benzinga.com New York State Department Of Health Provides Clinical Laboratory Evaluation Program Test Approval To Niki BioSolutions' DiamiR Biosciences Subsidiary For Its APOE Genotyping Test Niki BioSolutions, Inc. (NASDAQ: NIKI) ("Niki BioSolutions" or the "Company"), a clinical-stage life sciences company focused on developing advanced genomic and biomarker testing solutions, today
globenewswire.com Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine NYSDOH CLEP approval extends validated APOE genotyping beyond blood, buccal swab, saliva, and tissue for clinical and research use
globenewswire.com Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research Agreement brings CAP and NYS CLEP-approved genotyping test to a multi-site Alzheimer's clinical research network PRINCETON, NJ, NEW HAVEN, CT and ORLANDO, FL, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Niki…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA)…
globenewswire.com Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series Company's blood-based microRNA biomarker panel is designed to support monitoring of disease progression and treatment response in Rett syndrome
benzinga.com Niki BioSolutions' DiamiR Biosciences Subsidiary To Perform Apolipoprotein E Genotyping On Plasma Samples From Global Alzheimer’s Platform Foundation Bio-Hermes-002 Trial Group Niki BioSolutions, Inc. (NASDAQ: NIKI) ("Niki" or the "Company"), a clinical-stage life sciences company focused on unmet medical needs and genomic and biomarker testing solutions, today announced…
globenewswire.com Niki BioSolutions Partners with Global Alzheimer's Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002 Plasma-based APOE genotyping to add genetic risk data to a diverse, deeply characterized Alzheimer's biomarker cohort PRINCETON, N.J., and NEW HAVEN, Conn.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 20.5% to $3.65 during Tuesday's after-market session. The market value of their outstanding shares is at $2.6 million. Circle8 Group…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 141.2% to $2.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 million. DataMEDS AI…
- benzinga.com Niki BioSolutions Enters At The Market Offering Agreement On October 9, 2026; May Sell Common Stock Up To $1.40M Aggregate Maximum Offering Price Niki BioSolutions, Inc., a Delaware corporation (the "Company," "Niki," "we," "our," or "us"), has entered into an at-the-market issuance sales agreement, dated October 9, 2026
globenewswire.com Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference NEW HAVEN, CT and PRINCETON, NJ, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs and providing…
globenewswire.com Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform
globenewswire.com Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference Live company presentation will take place on September 14 at 10:30 AM ET NEW HAVEN, CT and PRINCETON, NJ, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…
benzinga.com Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research ProgramsNEW HAVEN, CT and PRINCETON, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc., a…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million. Apimeds Pharmaceuticals…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's regular session. The company's market cap stands at $36.8 million. Wellgistics Health (NASDAQ:WGRX) shares…